KFDA to control human tissue planting materials.

Published: 2004-02-18 06:59:00

Updated: 2004-02-18 06:59:00

The KFDA authorized Hans Biomed Inc. as the first company for the safety control of the human tissue transplanting materials, which had raised social problems before because of no national control system over its disease contagious risk and safety.

The KFDA therefore prepared a recommending d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK